DEUTSCHE BANK AG\ - AVALO THERAPEUTICS INC ownership

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 71 filers reported holding AVALO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$82,000
+24.2%
112,925
+188.1%
0.00%
Q4 2021$66,000
-4.3%
39,202
+23.3%
0.00%
Q3 2021$69,00031,7940.00%
Other shareholders

There were no reported owners of AVALO THERAPEUTICS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of AVALO THERAPEUTICS INC shareholders